Table 3 Comparison of outcomes associated with gout flare in heart transplant recipients supported with Impella
Overall (N = 42) | No gout flare (N = 29) | Gout flare (N = 13) | p-value | |
|---|---|---|---|---|
Outcomes; n (%) | ||||
In-hospital mortality | 4 (9.5) | 4 (14%) | 0 (0%) | 0.29 |
Hospital LOS (days); median (IQR) | 50 (42, 76) | 48 (37, 66) | 72 (54, 80) | 0.03 |
ICU LOS (days); median (IQR) | 25.50 (14, 42) | 19 (14, 33) | 44 (26, 57) | 0.017 |
IMV | 34 (81) | 23 (80%) | 11 (85%) | 1.00 |
IMV length (days) | 3 (2, 5) | 3 (2, 8) | 3 (2, 4) | 0.51 |
Acute Kidney Injury | 21 (50) | 16 (55%) | 5 (38%) | 0.51 |